PSYCHOTROPIC DISORDERS
Personalized drug therapy would have a positive effect on the management of this devastating illness.
According to the 2007 Behavioral Risk Factor Surveillance System
survey, 40% of U.S. residents in 35 states had serious psychological
distress.
Second-generation antipsychotics may cause weight gain, dyslipidemia, and hyperglycemia.
A behavioral emergency--also known as
clinically significant acute agitation--typically is a dynamic, unpredictable encounter with a patient in whom the diagnosis is unknown or preliminary.
Management of metabolic complications, including diabetes mellitus and metabolic syndrome, in the psychiatric patient is complex.
Antibiotics, cardiovascular medications, and analgesics should not be combined with alcohol.
A potentially lethal condition, serotonin syndrome is caused most
often when certain antidepressant agents are taken concurrently with
other drugs that modulate synaptic serotonin levels.
Symptoms of a panic attack can mimic those of a heart attack or nervous breakdown.
Psychotropic medications are a major resource in the treatment of mental disorders.
Sometimes called
manic depression, this form of a mental illness is described as a fluctuation in mood extremes.
Prolonged tiredness and sleepiness are a concern for many people.
For the community pharmacist, the ability to aid in the management of
opioid dependence is vital to closing the gap between treated and
untreated opioid-dependent individuals.
Research results in the emerging area of nutritional neuroscience point to a link between what people eat and the quality of their mental state.
Alcohol dependence is a serious health concern that is associated with many long-term consequences.
Owing to the complex nature of schizophrenia, treatment typically involves both pharmacologic and nonpharmacologic therapies.
These agents are equal in effectiveness, but it is hard to predict which one will work best for a given patient.
In the public-health setting, a variety of mental-health conditions
ranging from depression to bipolar disorder are encountered, but
these illnesses are not always treated appropriately during pregnancy.
This preparation can be used in patients who have difficulty swallowing pills or in those for whom other administration routes are not desirable.
While the birth of a child is exciting and monumental, many women experience short- or long-term mood disturbances in the postpartum period.
Attention-deficit/hyperactivity disorder (ADHD) and learning disability (LD) are two of the most prevalent disorders occurring in children aged 6 to 17 years.
First described more than 40 years ago, serotonin syndrome remains unfamiliar to most clinicians.
On a regular basis, most pharmacists must interact with patients who have mental illnesses.
An eating disorder is an abnormal eating behavior that leads to serious physical and emotional problems.
The FDA has broadened the indications for methylphenidate (Concerta) extended-release tablets in doses of 18 mg to 72 mg/day to include adults with attention-deficit hyperactivity disorder (ADHD).
The FDA has acted to require manufacturers of an older class of drugs known as conventional antipsychotics to add boxed warnings to their labeling about an increased risk of death associated with their off-label use to treat behavioral problems in older patients with dementia.
Adverse drug reactions are a potential problem with all medications.
Attention-deficit hyperactivity disorder (ADHD) is characterized by inattentiveness, impulsivity, and/or hyperactivity and represents a common behavioral disorder of childhood.
Serious psychological disorders (SPD) such as anxiety, depression, schizophrenia, and attention-deficit disorder have contributed to 48 million office-based physician visits, 3.7 million emergency department visits, 5.
With the increasing development of newer and more complex drug compounds, pharmacists are being asked to bear much of the burden for detecting, preventing, and resolving adverse drug reactions and potentially serious drug interactions.
Seasonal affective disorder, or SAD, is a type of depression that occurs each year around the same time, usually during the fall and winter months.
Atipsychotic medications are the mainstays for treating a number of serious psychiatric disorders, including schizophrenia, mania, delusional disorder, and psychosis.
The potential number of interactions between nonprescription products and psychotropic medications is difficult to estimate due to the number of OTC products and the immense probability that many will interact with psychotropics.
Borderline personality disorder (BPD) is a psychiatric condition in which patients display a "pervasive pattern of instability of interpersonal relationships, self-image, affects, and marked impulsivity that begins by early adulthood and is present in a variety of contexts.
Bipolar disorder, also commonly referred to as manic depression, is a diagnosis of brain dysfunction characterized by severe alterations in mood and energy with a diminished capacity for daily functioning.
Obsessive-compulsive disorder (OCD) is a type of anxiety disorder that is named for its symptoms.
Omega-3 Fatty Acids Reduce Risk of Type 1 Diabetes in Children Preliminary research published in a recent issue of JAMA suggests that the dietary intake of omega-3 fatty acids by children at increased genetic risk for type 1 diabetes is associated with a reduced risk of pancreatic islet autoimmunity, which is linked to the development of this disease.
Depression is prevalent, and the highest incidence for onset in women is during the childbearing years.